awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34064466-78167726-D79B-462E-81A8-BFE712F58330
Q34064466-78167726-D79B-462E-81A8-BFE712F58330
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34064466-78167726-D79B-462E-81A8-BFE712F58330
Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma
P2860
Q34064466-78167726-D79B-462E-81A8-BFE712F58330
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34064466-78167726-D79B-462E-81A8-BFE712F58330
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a4b8e741fae342604a3e3c1445aa4e6bc61d4a1
P2860
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized